P
Precipio D
D
PRPO
27.260
USD
-1.28
(-4.48%)
Market Closed
Volume
3,350
EPS
0
Div Yield
-
P/E
-44
Market Cap
48,800,525
Articles
Title: Precipio
Sector: Healthcare
Industry: Diagnostics & Research
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
